Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Mar;76(3):190–196. doi: 10.1136/adc.76.3.190

Survival and endocrine outome after testicular relapse in acute lymphoblastic leukaemia

R Grundy 1, A Leiper 1, R Stanhope 1, J Chessells 1
PMCID: PMC1717105  PMID: 9135257

Abstract

Accepted 4 November 1996


Survival and endocrine status in a cohort of boys with acute lymphoblastic leukaemia (ALL) who started treatment between 1972and 1987 and subsequently developed a testicular relapse were analysed. During this period there was a significant improvement in the overall event free survival for boys, but no significant decrease in the testicular relapse rate. Thirty three boys had an apparently isolated testicular relapse, whereas 21 boys had a combined relapse. The event free survival for boys with an isolated testicular relapse was 59% at six years (95% confidence interval (CI) 42 to 74%). The event free survival for the 16 patients with a combined relapse who received a second course of treatment was 32% (95% CI 17 to 60%). Those patients receiving adequate second line treatment for an isolated testicular relapse whose first remission was longer than or equal to two years had an event free survival of 82% (95% CI 63 to 93%) at six years. No boy relapsing within two years from diagnosis has survived. Endocrine late effects are significant, with 82% of the boys requiring hormonal treatment at some stage for induction of puberty or continuing pubertal maturation, or both. It is concluded that, despite the increasing intensity of initial treatment for ALL, isolated testicular relapse is treatable by conventional means in most patients. Careful endocrine follow up of these patients is essential as most will require hormone replacement treatment.



Full Text

The Full Text of this article is available as a PDF (124.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askin F. B., Land V. J., Sullivan M. P., Ragab A. H., Steuber C. P., Dyment P. G., Talbert J., Moore T. Occult testicular leukemia: testicular biopsy at three years continuous complete remission of childhood leukemia: a Southwest Oncology Group Study. Cancer. 1981 Feb 1;47(3):470–475. doi: 10.1002/1097-0142(19810201)47:3<470::aid-cncr2820470308>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  2. Baum E., Heyn R., Nesbit M., Tilford D., Nachman J. Occult abdominal involvement with apparently isolated testicular relapse in children with acute lymphocytic leukemia. Am J Pediatr Hematol Oncol. 1984 Fall;6(3):343–346. [PubMed] [Google Scholar]
  3. Blatt J., Poplack D. G., Sherins R. J. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981 May 7;304(19):1121–1124. doi: 10.1056/NEJM198105073041901. [DOI] [PubMed] [Google Scholar]
  4. Blatt J., Sherins R. J., Niebrugge D., Bleyer W. A., Poplack D. G. Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol. 1985 Sep;3(9):1227–1231. doi: 10.1200/JCO.1985.3.9.1227. [DOI] [PubMed] [Google Scholar]
  5. Bowman W. P., Aur R. J., Hustu H. O., Rivera G. Isolated testicular relapse in acute lymphocytic leukemia of childhood: categories and influence on survival. J Clin Oncol. 1984 Aug;2(8):924–929. doi: 10.1200/JCO.1984.2.8.924. [DOI] [PubMed] [Google Scholar]
  6. Brauner R., Czernichow P., Cramer P., Schaison G., Rappaport R. Leydig-cell function in children after direct testicular irradiation for acute lymphoblastic leukemia. N Engl J Med. 1983 Jul 7;309(1):25–28. doi: 10.1056/NEJM198307073090106. [DOI] [PubMed] [Google Scholar]
  7. Brecher M. L., Weinberg V., Boyett J. M., Sinks L. F., Jones B., Glicksman A., Holland J. F., Freeman A. I. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse. Cancer. 1986 Sep 1;58(5):1024–1028. doi: 10.1002/1097-0142(19860901)58:5<1024::aid-cncr2820580507>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  8. Byrd R. L. Proceedings of the tumor board of the Children's Hospital of Philadelphia. Testicular leukemia: incidence and management results. Med Pediatr Oncol. 1981;9(5):493–500. doi: 10.1002/mpo.2950090513. [DOI] [PubMed] [Google Scholar]
  9. Castillo L. A., Craft A. W., Kernahan J., Evans R. G., Aynsley-Green A. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia. Med Pediatr Oncol. 1990;18(3):185–189. doi: 10.1002/mpo.2950180304. [DOI] [PubMed] [Google Scholar]
  10. Chan K. W., Wood B. J., Johnson H. W. Testicular adhesion: a potential complication from wedge testicular biopsy in childhood leukemia. Med Pediatr Oncol. 1988;16(5):366–367. doi: 10.1002/mpo.2950160516. [DOI] [PubMed] [Google Scholar]
  11. Chessells J. M., Bailey C., Richards S. M. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet. 1995 Jan 21;345(8943):143–148. doi: 10.1016/s0140-6736(95)90164-7. [DOI] [PubMed] [Google Scholar]
  12. Chessells J. M., Leiper A. D., Tiedemann K., Hardisty R. M., Richards S. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia. Arch Dis Child. 1987 Feb;62(2):172–176. doi: 10.1136/adc.62.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chessells J. M., Richards S. M., Bailey C. C., Lilleyman J. S., Eden O. B. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol. 1995 Feb;89(2):364–372. doi: 10.1111/j.1365-2141.1995.tb03313.x. [DOI] [PubMed] [Google Scholar]
  14. Didi M., Morris-Jones P. H., Gattamaneni H. R., Shalet S. M. Pubertal growth in response to testosterone replacement therapy for radiation-induced Leydig cell failure. Med Pediatr Oncol. 1994;22(4):250–254. doi: 10.1002/mpo.2950220407. [DOI] [PubMed] [Google Scholar]
  15. Eden O. B., Lilleyman J. S., Richards S. Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods. Br J Haematol. 1990 Aug;75(4):496–498. doi: 10.1111/j.1365-2141.1990.tb07788.x. [DOI] [PubMed] [Google Scholar]
  16. Eden O. B., Rankin A., Kay H. E. Isolated testicular relapse in acute lymphoblastic leukaemia of childhood. Report on behalf of the Medical Research Council's working party on leukaemia in childhood. Arch Dis Child. 1983 Feb;58(2):128–132. doi: 10.1136/adc.58.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Forrest J. B., Turner T. T., Howards S. S. Cyclophosphamide and blood-testis barrier. Surg Forum. 1979;30:552–553. [PubMed] [Google Scholar]
  18. Freeman A. I., Weinberg V., Brecher M. L., Jones B., Glicksman A. S., Sinks L. F., Weil M., Pleuss H., Hananian J., Burgert E. O., Jr Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. N Engl J Med. 1983 Mar 3;308(9):477–484. doi: 10.1056/NEJM198303033080902. [DOI] [PubMed] [Google Scholar]
  19. Goulden N., Langlands K., Steward C., Katz F., Potter M., Chessells J., Oakhill A. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. Br J Haematol. 1994 Jun;87(2):282–285. doi: 10.1111/j.1365-2141.1994.tb04910.x. [DOI] [PubMed] [Google Scholar]
  20. Kay H. E. Testicular infiltration in acute lymphoblastic leukaemia. Br J Haematol. 1983 Apr;53(4):537–542. doi: 10.1111/j.1365-2141.1983.tb07305.x. [DOI] [PubMed] [Google Scholar]
  21. Lanning M., Garwicz S., Hertz H., Jonmundsson G., Kreuger A., Lie S. O., Moe P. J., Salmi T. T., Schröder H., Siimes M. A. Superior treatment results in females with high-risk acute lymphoblastic leukemia in childhood. Acta Paediatr. 1992 Jan;81(1):66–68. doi: 10.1111/j.1651-2227.1992.tb12081.x. [DOI] [PubMed] [Google Scholar]
  22. Leiper A. D., Grant D. B., Chessells J. M. Gonadal function after testicular radiation for acute lymphoblastic leukaemia. Arch Dis Child. 1986 Jan;61(1):53–56. doi: 10.1136/adc.61.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Moe P. J., Seip M., Finne P. H. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program. Acta Paediatr Scand. 1981 Jan;70(1):73–79. doi: 10.1111/j.1651-2227.1981.tb07176.x. [DOI] [PubMed] [Google Scholar]
  24. Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nachman J., Palmer N. F., Sather H. N., Bleyer W. A., Coccia P. F., Lukens J. N., Siegel S. E., Hammond G. D. Open-wedge testicular biopsy in childhood acute lymphoblastic leukemia after two years of maintenance therapy: diagnostic accuracy and influence on outcome--a report from Children's Cancer Study Group. Blood. 1990 Mar 1;75(5):1051–1055. [PubMed] [Google Scholar]
  26. Nesbit M. E., Jr, Robison L. L., Ortega J. A., Sather H. N., Donaldson M., Hammond D. Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Childrens Cancer Study Group. Cancer. 1980 Apr 15;45(8):2009–2016. doi: 10.1002/1097-0142(19800415)45:8<2009::aid-cncr2820450805>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  27. Oakhill A., Mainwaring D., Hill F. G., Gornall P., Cudmore R. E., Banks A. J., Brock J. E., Martin J., Mann J. R. Management of leukaemic infiltration of the testis. Arch Dis Child. 1980 Jul;55(7):564–566. doi: 10.1136/adc.55.7.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Prader A. Testicular size: assessment and clinical importance. Triangle. 1966;7(6):240–243. [PubMed] [Google Scholar]
  29. Quigley C., Cowell C., Jimenez M., Burger H., Kirk J., Bergin M., Stevens M., Simpson J., Silink M. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med. 1989 Jul 20;321(3):143–151. doi: 10.1056/NEJM198907203210303. [DOI] [PubMed] [Google Scholar]
  30. Reiter A., Schrappe M., Ludwig W. D., Hiddemann W., Sauter S., Henze G., Zimmermann M., Lampert F., Havers W., Niethammer D. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994 Nov 1;84(9):3122–3133. [PubMed] [Google Scholar]
  31. Riccardi R., Vigersky R. A., Barnes S., Bleyer W. A., Poplack D. G. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res. 1982 May;42(5):1617–1619. [PubMed] [Google Scholar]
  32. Shalet S. M., Hann I. M., Lendon M., Morris Jones P. H., Beardwell C. G. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child. 1981 Apr;56(4):275–278. doi: 10.1136/adc.56.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shalet S. M., Horner A., Ahmed S. R., Morris-Jones P. H. Leydig cell damage after testicular irradiation for lymphoblastic leukaemia. Med Pediatr Oncol. 1985;13(2):65–68. doi: 10.1002/mpo.2950130204. [DOI] [PubMed] [Google Scholar]
  34. Sklar C. A., Robison L. L., Nesbit M. E., Sather H. N., Meadows A. T., Ortega J. A., Kim T. H., Hammond G. D. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol. 1990 Dec;8(12):1981–1987. doi: 10.1200/JCO.1990.8.12.1981. [DOI] [PubMed] [Google Scholar]
  35. Steinfeld A. D. Radiation therapy in the treatment of leukemic infiltrates of the testes. Radiology. 1976 Sep;120(3):681–682. doi: 10.1148/120.3.681. [DOI] [PubMed] [Google Scholar]
  36. Stoffel T. J., Nesbit M. E., Levitt S. H. Extramedullary involvement of the testes in childhood leukemia. Cancer. 1975 Apr;35(4):1203–1211. doi: 10.1002/1097-0142(197504)35:4<1203::aid-cncr2820350426>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  37. Sullivan M. P., Perez C. A., Herson J., Silva-Sousa M., Land V., Dyment P. G., Chan R., Ayala A. G. Radiotherapy (2500 rad) for testicular leukemia: local control and subsequent clinical events: a Southwest Oncology Group study. Cancer. 1980 Aug 1;46(3):508–515. doi: 10.1002/1097-0142(19800801)46:3<508::aid-cncr2820460315>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  38. Tiedemann J., Chessells J. M., Sandland R. M. Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome. Br Med J (Clin Res Ed) 1982 Dec 4;285(6355):1614–1616. doi: 10.1136/bmj.285.6355.1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tombolini V., Banelli E., Capua A., Giona F., Vitturini A. Radiation treatment of testicular relapse in acute lymphoblastic leukemia. Acta Radiol Oncol. 1986 Jan-Feb;25(1):29–32. doi: 10.3109/02841868609136373. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES